Pharmaceuticals | Citizens Against Government Waste
The WasteWatcher: The Staff Blog of Citizens Against Government Waste

Pharmaceuticals

House Speaker Pelosi's Bizarre Drug Price Negotiation Plan

Speaker Nancy Pelosi (D-Calif.) is expected to soon release her long-awaited drug pricing proposal.  According to news reports, the plan is expected to require the Department of Health and Human Services (HHS) to directly “negotiate” with pharmaceutical manufacturers for an “acceptable” price for at least 25 drugs that would apply to the entire U.S. market.  If no agreement can be reached, the Government Accountability Office would act as an arbitrator and oversee a dispute resolution.

U.S. Should Not Import Foreign Price Controls on Drugs

On May 20, 2019, Health and Human Services (HHS) Secretary Alex Azar, spoke before the 72nd World Health Assembly, the decision-making body of the World Health Organization (WHO) under the United Nations (UN), in Geneva, Switzerland. This assembly is held annually and attended by delegations from the 150 WHO member states, including the United States.

Higher Taxes on Pharmaceuticals Will Not Solve the Opioid Crisis

It is common knowledge that addiction to opioids and other controlled substances such as fentanyl is a national epidemic that needs to be addressed.  But, the plans being offered by Minnesota Governor Tim Waltz and the state legislature will drive up pharmaceutical costs, hurt patients, and fail to solve the opioid crisis in Minnesota.

They’re Baaaaack – The Sequel

In their never-ending quest to run roughshod and exert control over the research-intensive biopharmaceutical industry, socialists in Congress have introduced various price-control bills.  For some reason they continue to think innovative drugs that cure cancer or other chronic diseases, such as hepatitis C, are whipped up in a back room with a 1970s-style “

Using an International Pricing Index is NOT the Way to Lower Drug Costs

On December 6, John O’Brien, the senior advisor on drug pricing reform to Health and Human Services (HHS) Secretary Alex Azar, published a blog, entitled, “How the IPI Model Would Introduce New Market Competition to Medicare Drug Spending.”  The blog left a lot of fiscal conservatives and patient-centered, free-market healthcare advocates scratching their heads.  Mr.

New HHS Transparency Regulation Mandates Inaccurate Information

The Pharmaceutical Research Manufacturers Association (PhRMA), the trade association that represents the nation’s leading biopharmaceutical research companies, announced a new proposal on Monday regarding direct-to-consumer (DTC) television advertising.  This voluntary agreement by PhRMA members would help patients access more useful information about the cost of their medicines.

Importation Will Not Lower Drug Costs

Citizens Against Government Waste (CAGW) was disappointed to see that the Trump Administration announced on Thursday, July 19, that the Food and Drug Administration (FDA) is exploring ways to import lower cost drugs from foreign countries.  Since most countries utilize price controls to determine a drug’s cost, the U.S.

President Trump’s Blueprint to Lower Drug Costs: A Lot to Unpack

On Friday, May 11, President Trump released his report on what his administration will do to lower drug costs.

President Trump's Drug Costs Proposals Coming Soon

The President has already made some good policy decisions and has offered other proposals that will help to lower drug costs.

Stealing Patents Won’t Bring Down Drug Costs

On February 15, 2018, 18 Democratic members of Congress sent a letter to Health and Human Services (HHS) Secretary Alex Azar, asking him to use his authority under 28 U.S.C.

Pages

Sign Up for Email Updates!Click Here!

View Archives

Posts by Author

Posts by Tag

Big Government (152) Obamacare (84) Congress (78) Waste (74) Healthcare (74) Budget (72) Uncategorized (56) Telecommunications (50) Internet (49) Debt (47) Technology (46) Deficit (44)